Sign in

Lost your password?
(close)

Japan

Japan / Taiho Pharmaceutical: An Oral Chemotherapy Pioneer

Japanese pharma companies are already far lower-profile than their occidental counterparts but an even lesser-known player may be Taiho Pharmaceutical, a Japanese specialty pharma player that was a pioneer in…

UK-Japan FTA / Banishing UK Pharma's Brexit Blues

The signing of an agreement on the terms of a future trade relationship between Japan and the UK has been welcomed…

Japan / The Latest Therapeutic Applications in Induced Pluripotent Stem Cell (iPSC) Technology

Toshio Fujimoto, MBA, MD of Japan’s Shonan Health Innovation Park looks at how a technology developed in Japan…

Japan / Eisai Targeting Global Leadership in Neurology & Oncology Niches

Founded by Toyoji Naito in December 1941, in just under 80 years, Eisai has become a leading global biopharma…

In Conversation

Ken-ichiro Hata – Representative Director & Chairperson, Forum for Innovative Regenerative Medicine (FIRM), Japan

Dr Ken-ichiro Hata, representative director and chairperson of Japan’s Forum for Innovative Regenerative Medicine (FIRM) outlines the organisation’s mandate, how Japan has been able to cultivate one of the world’s most mature regenerative medicine ecosystems, and highlights key challenges including regulatory misalignment across Asia and the need for better manufacturing and commercialisation models.   We are confident that 2020 and…

Yoji Yuki – CEO, UniBio Corporation

Ryu Ogawa – CEO & Satoshi Tamaki – CSO,…

Japan / PMDA New Drug Approvals 2020

Following on from our recent compilations of 2020 new drug approvals in the USA, China, and Switzerland, see below…

Strategy / Japanese Pharma’s Skyrocketing US Footprint

Following PharmaBoardroom’s recent interview with Ivan Cheung, chairman of Eisai’s US affiliate and president…

Japan / PMDA New Drug Approvals 2020

Following on from our recent compilations of 2020 new drug approvals in the USA, China, and Switzerland, see below…

Opinion / Maintaining Open Innovation in Our ‘New Normal’ Through Virtual Collaboration

Toshio Fujimoto, MBA, MD of Japan’s Shonan Health Innovation Park explores new ways of virtual collaboration that…

We use cookies to ensure that we give you the best experience on our site. For more info click here